Abstract
Objective While external beam radiotherapy (RT) is a widely used modality to attempt to arrest bleeding in advanced bladder cancer, the evidentiary base to support its use is relatively modest. The aims of this analysis were to determine the likelihood and duration of hemostasis following palliative external beam RT for primary bladder carcinoma with uncontrolled bleeding and to identify clinical and pathologic factors that influence duration of hemostasis.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
